Clinical Trials Recruiting near Miami, FL

1,637 clinical trials have a recruiting site within 25 miles of Miami, Florida, according to ClinicalTrials.gov data processed October 15, 2026. The closest recruiting site is within 1 mile of the city center.

Distances are measured from the city center to each site's city, so they are approximate.

Recruiting now

Studies enrolling near Miami

Showing 30 studies, nearest first.

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
NCT03072927
- Observational
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
33 sites within 25 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949
- Phase 3
- Ages 55 to 90 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
32 sites within 25 mi
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
NCT07519395
- Phase 2
- Ages 18 to 80 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
17 sites within 25 mi
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
NCT07805707
- Phase 3
- Ages 65 years and older
- Sex: All
- Accepts healthy volunteers
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
16 sites within 25 mi
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
15 sites within 25 mi
ACP-204 in Adults With Alzheimer's Disease Psychosis
NCT06159673
- Phase 2/3
- Ages 55 to 95 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
14 sites within 25 mi
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
14 sites within 25 mi
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
NCT06152575
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
13 sites within 25 mi
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
NCT06316297
- Phase 1/2
- Ages 18 to 45 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
13 sites within 25 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
13 sites within 25 mi
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
NCT07214571
- Phase 2
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
13 sites within 25 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT05879926
- Phase 3
- Ages 18 to 60 years
- Sex: Female
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
12 sites within 25 mi
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214
- Phase 3
- Ages 40 to 80 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
12 sites within 25 mi
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
NCT07061977
- Phase 3
- Ages 18 years and older
- Sex: Female
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
12 sites within 25 mi
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
NCT07133308
- Phase 3
- Ages 12 to 17 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
12 sites within 25 mi
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
NCT07000357
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
11 sites within 25 mi
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
NCT07221227
- Phase 3
- Ages 18 to 75 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
11 sites within 25 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961
- Phase 2/3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
NCT05987241
- Phase 2/3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
NCT06229210
- Phase 3
- Ages 5 to 17 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
NCT06337318
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
NCT06679140
- Phase 3
- Ages 12 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433
- Phase 3
- Ages 45 to 99 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
NCT07221188
- Phase 3
- Ages 18 to 75 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
NCT07271186
- Phase 2
- Ages 18 to 80 years
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
NCT07388498
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
10 sites within 25 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
NCT02693535
- Phase 2
- Ages 12 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
9 sites within 25 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418
- Interventional
- Ages 55 years and older
- Sex: All
- Accepts healthy volunteers
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
9 sites within 25 mi
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
NCT06592924
- Phase 3
- Ages 18 years and older
- Sex: Male
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
9 sites within 25 mi
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
NCT06667700
- Phase 3
- Ages 18 years and older
- Sex: All
Distance to nearest recruiting site
<1 mi (city-level)
Recruiting sites
9 sites within 25 mi

Source: ClinicalTrials.gov, data processed October 15, 2026. Recruiting US sites filtered by distance and site status; summaries shortened.